These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25996400)

  • 1. Prion aggregates transfer through tunneling nanotubes in endocytic vesicles.
    Zhu S; Victoria GS; Marzo L; Ghosh R; Zurzolo C
    Prion; 2015; 9(2):125-35. PubMed ID: 25996400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocyte-to-neuron intercellular prion transfer is mediated by cell-cell contact.
    Victoria GS; Arkhipenko A; Zhu S; Syan S; Zurzolo C
    Sci Rep; 2016 Feb; 6():20762. PubMed ID: 26857744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The highways and byways of prion protein trafficking.
    Campana V; Sarnataro D; Zurzolo C
    Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prions hijack tunnelling nanotubes for intercellular spread.
    Gousset K; Schiff E; Langevin C; Marijanovic Z; Caputo A; Browman DT; Chenouard N; de Chaumont F; Martino A; Enninga J; Olivo-Marin JC; Männel D; Zurzolo C
    Nat Cell Biol; 2009 Mar; 11(3):328-36. PubMed ID: 19198598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the role of dendritic cells in prion transfer to primary neurons.
    Langevin C; Gousset K; Costanzo M; Richard-Le Goff O; Zurzolo C
    Biochem J; 2010 Oct; 431(2):189-98. PubMed ID: 20670217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrP(C) in highly susceptible Tga20 mice.
    Määttänen P; Taschuk R; Ross L; Marciniuk K; Bertram L; Potter A; Cashman NR; Napper S
    Prion; 2013; 7(5):434-9. PubMed ID: 24105298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
    Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
    Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular mechanisms responsible for cell-to-cell spreading of prions.
    Vilette D; Courte J; Peyrin JM; Coudert L; Schaeffer L; Andréoletti O; Leblanc P
    Cell Mol Life Sci; 2018 Jul; 75(14):2557-2574. PubMed ID: 29761205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
    Pimpinelli F; Lehmann S; Maridonneau-Parini I
    Eur J Neurosci; 2005 Apr; 21(8):2063-72. PubMed ID: 15869502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells.
    Yamasaki T; Baron GS; Suzuki A; Hasebe R; Horiuchi M
    Virology; 2014 Feb; 450-451():324-35. PubMed ID: 24503096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the anti-prion mechanism of four different anti-prion compounds, anti-PrP monoclonal antibody 44B1, pentosan polysulfate, chlorpromazine, and U18666A, in prion-infected mouse neuroblastoma cells.
    Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    PLoS One; 2014; 9(9):e106516. PubMed ID: 25181483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.
    Jeffrey M; McGovern G; Sisó S; González L
    Acta Neuropathol; 2011 Jan; 121(1):113-34. PubMed ID: 20532540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles.
    Alais S; Simoes S; Baas D; Lehmann S; Raposo G; Darlix JL; Leblanc P
    Biol Cell; 2008 Oct; 100(10):603-15. PubMed ID: 18422484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells.
    Magalhães AC; Baron GS; Lee KS; Steele-Mortimer O; Dorward D; Prado MA; Caughey B
    J Neurosci; 2005 May; 25(21):5207-16. PubMed ID: 15917460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stressing out the ER: a role of the unfolded protein response in prion-related disorders.
    Hetz CA; Soto C
    Curr Mol Med; 2006 Feb; 6(1):37-43. PubMed ID: 16472111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
    Shim SY; Karri S; Law S; Schatzl HM; Gilch S
    Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
    Shoup D; Priola SA
    Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the neurospecificity of Prion protein signaling.
    Schneider B; Pietri M; Pradines E; Loubet D; Launay JM; Kellermann O; Mouillet-Richard S
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):169-86. PubMed ID: 21196165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.